Oncodesign Precision Medicine (XPAR:ALOPM) EBIT per Share : €-0.43 (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine EBIT per Share?

Oncodesign Precision Medicine's EBIT per Share for the six months ended in Dec. 2024 was €-0.19. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.43.

During the past 3 years, the average EBIT per Share Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Oncodesign Precision Medicine's EBIT per Share or its related term are showing as below:

XPAR:ALOPM' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 4.8 Med: 8.75 Max: 12.7
Current: 4.8

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Oncodesign Precision Medicine was 12.70% per year. The lowest was 4.80% per year. And the median was 8.75% per year.

XPAR:ALOPM's 3-Year EBIT Growth Rate is ranked worse than
55.75% of 1234 companies
in the Biotechnology industry
Industry Median: 9 vs XPAR:ALOPM: 4.80

Oncodesign Precision Medicine's EBIT for the six months ended in Dec. 2024 was €-3.52 Mil.

Oncodesign Precision Medicine EBIT per Share Historical Data

The historical data trend for Oncodesign Precision Medicine's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine EBIT per Share Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

-0.90

-0.54

-0.10

-0.58

-0.45

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial			0.14	-0.28	-0.30	-0.24	-0.19

Oncodesign Precision Medicine EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Oncodesign Precision Medicine's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.522	/	18.168
=	-0.41

Oncodesign Precision Medicine's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.522	/	18.168
=	-0.19

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.43

Oncodesign Precision Medicine (XPAR:ALOPM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Oncodesign Precision Medicine EBIT per Share Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ZR8:Germany

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines